Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,444.25
(
0.58%
)
US TECH 100
28,654.40
(
1.29%
)
Dow Jones
49,693.20
(
-0.14%
)
Brent Oil
103.69
(
-1.96%
)
Bitcoin
79,350.52
(
-1.42%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biopharm

Send PM Follow Ignore
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

biopharm

Re: biopharm post# 223399

Monday, 06/15/2015 9:01:55 AM

Monday, June 15, 2015 9:01:55 AM

Post# of 347009
Scott Antonia : Peregrine Pharmaceuticals KOL

Dr. Eric Haura and Dr. Scott Antonia take us Behind The Science as they dive deep into the workings of the immune system and how it relates to cancer treatment and care.

Behind the Science -Episode 3 -Chapter 1 - The Immune System
Introductions and how the immune system works.

"..or really the bigger problem is the cancer has developed ways to evade that immune system.."

https://www.facebook.com/MoffittCancerCenter/posts/10153355221377509

----------------------



"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote